Table 2.
AMH and pituitary-gonadal hormones (median ± SD) observed during the menstrual cycle; see also protocol section. Median and 25th and 75th percentile values are reported in brackets
| Group 1 n = 59 |
Group 2 n = 30 |
Group 3 n = 141 |
Significance P | |
|---|---|---|---|---|
| AMH (pmol/l) | 9.79 ± 11.46 (7.14;1.57–12.29) | 8.71 ± 10.54 (3.75;1.48–16.13) | 21.28 ± 23.82 (13.50; 5.14–29.32) | < 0.0001; a |
| FSH (IU/l) | 12.6 ± 12.4 (8.6; 6.2–13.8) | 15.3 ± 15.4 (11.0; 6.6–17.9) | 10.1 ± 12.0 (6.8; 4.9–10.2) | 0.005; b |
| Estradiol (pmol/l) | 210.8 ± 87.6 (176.2; 147–247) | 162.8 ± 65.9 (168.9; 109–209) | 204.1 ± 171.3 (157.9;105–209) | 0.10 |
| Progesterone (nmol/l) | 22.2 ± 18.1 (22.3; 4.8–33.5) | 25.2 ± 16.6 (23.4; 14.9–36.4) | 23.0 ± 24.2 (19.5; 3.7–30.2) | 0.64 |
| PRL (μg/l) | 12.3 ± 8.5 (9.6; 6.3–16.0) | 13.8 ± 6.6 (13.7; 7.6–17.7) | 14.8 ± 8.4 (13.3; 8.5–18.6) | 0.06 |
(When ANOVA was significant, differences among groups were evaluated by means of Dunn’s test. a) AMH: group 3 vs group 1, P = 0.0002 and group 3 vs group 2, P = 0.001; b) FSH: group 3 vs group 1, P = 0.01; group 3 vs group 2, P = 0.06)